2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版)

2021-04-15 Chin Med J (Engl).2021 Apr 15.

2021年4月,中国乳腺外科学会(CSBrS)发布了乳腺纤维腺瘤管理指南,本文为该指南的英文版本。CSBrS专家小组主要针对乳腺纤维腺瘤的诊断和手术治疗提供指导建议。

中文标题:

2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版)

英文标题:

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

发布机构:

发布日期:

2021-04-15

简要介绍:

2021年4月,中国乳腺外科学会(CSBrS)发布了乳腺纤维腺瘤管理指南,本文为该指南的英文版本。CSBrS专家小组主要针对乳腺纤维腺瘤的诊断和手术治疗提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=bb9ae1c002093324, title=2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版), enTitle=Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021, guiderFrom=Chin Med J (Engl).2021 Apr 15., authorId=0, author=, summary=2021年4月,中国乳腺外科学会(CSBrS)发布了乳腺纤维腺瘤管理指南,本文为该指南的英文版本。CSBrS专家小组主要针对乳腺纤维腺瘤的诊断和手术治疗提供指导建议。, cover=https://img.medsci.cn/202158/1620487710688_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Apr 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月,中国乳腺外科学会(CSBrS)发布了乳腺纤维腺瘤管理指南,本文为该指南的英文版本。CSBrS专家小组主要针对乳腺纤维腺瘤的诊断和手术治疗提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=20038, tagName=乳腺纤维腺瘤)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=20038, guiderKeyword=乳腺纤维腺瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8107, appHits=122, showAppHits=0, pcHits=746, showPcHits=7985, likes=1, shares=4, comments=3, approvalStatus=1, publishedTime=Sat May 08 23:28:46 CST 2021, publishedTimeString=2021-04-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 08 23:28:36 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 01:11:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版).pdf)])
2021 CSBrS临床实践指南:乳腺纤维腺瘤(英文版).pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200984, encodeId=10c7120098436, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Mar 09 18:25:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015717, encodeId=bc251015e176d, content=OK的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:51:44 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963945, encodeId=b82496394594, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/796bab196b324acd8a55201fd2ffaaec/91fdf1afa56e45d9a99a49626334c0fd.jpg, createdBy=f00f5496121, createdName=血白hq, createdTime=Sun May 09 13:02:18 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2022-03-09 严谨yyy

    想学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200984, encodeId=10c7120098436, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Mar 09 18:25:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015717, encodeId=bc251015e176d, content=OK的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:51:44 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963945, encodeId=b82496394594, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/796bab196b324acd8a55201fd2ffaaec/91fdf1afa56e45d9a99a49626334c0fd.jpg, createdBy=f00f5496121, createdName=血白hq, createdTime=Sun May 09 13:02:18 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-09-08 ms6000001820586697

    OK的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200984, encodeId=10c7120098436, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0d20efa54fee49fba0580eddbd3866c6/3e960aa8346342ec837310996af96e30.jpg, createdBy=ebea5209167, createdName=严谨yyy, createdTime=Wed Mar 09 18:25:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015717, encodeId=bc251015e176d, content=OK的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:51:44 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963945, encodeId=b82496394594, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/796bab196b324acd8a55201fd2ffaaec/91fdf1afa56e45d9a99a49626334c0fd.jpg, createdBy=f00f5496121, createdName=血白hq, createdTime=Sun May 09 13:02:18 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 血白hq

    0